Darren commenced Urology practice in 2007 at South Terrace Urology, following a fellowship at Sir Charles Gairdner Hospital in Perth, where he gained experience in transperineal ultrasound access for low and high dose rate brachytherapy. He is very experienced in the transperineal prostate biopsy, having performed more than 3000 since 2014.
- Senior Lecturer at Flinders University of South Australia
- Clinical Senior Lecturer at University of Adelaide
- Member of the Research Committee of South Australian Prostate Cancer Clinical Outcomes Collaborative (SAPCCOC)
- In February 2013 received a Repat Foundation grant for his study: ‘Does active surveillance and delayed treatment harm men with low risk prostate cancer?’
- Actively involved in prostate cancer research, as outlined below
Transperineal prostate biopsy advantages
- Near zero infection risk
- Accurate targeting of abnormal areas identified on MRI
- Allows access to anterior (front) part of prostate
RECENT PROSTATE CANCER MANUSCRIPTS
Kinnear N, Kichenadasse G, Plagakis S, OCallaghan M, Kopsaftis T, Walsh S, Foreman D.
Prostate cancer in men aged less than 50 years at diagnosis.
World Journal of Urology 2016 doi 10.1007/s00345-016-1824-4
Hoffmann R, Logan C, OCallaghan M, Gormley K, Chan K, Foreman D.
Does the Prostate Imaging- Reporting and Data System (PI-RADS) version 2 improve accuracy in reporting anterior lesions on multi parametric magnetic resonance imaging (mpMRI)?
International Urology and Nephrology 2018; 50: 13-19 doi: 10.1007/s11255-017-1753-1
RECENT PROSTATE CANCER PUBLISHED ABSTRACTS
Lin D, Plagakis S, OCallaghan M, Neumann P, Fuller A, Wells R, Sutherland P, Foreman D.
Does age, BMI or prostate volume affect continence outcomes following robot assisted laparoscopic radical prostatectomy (RALP)?
BJU International 2017; 119(S2): 28
Hoffmann R, Kahokehr A, OCallaghan M, Foreman D.
Localised very high risk prostate cancer.
BJU International 2017; 119(S2): 24